Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Dig Surg ; 32(4): 262-8, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26022344

RESUMO

BACKGROUND: Preoperative placement of self-expanding metal stents is used in patients with obstructing colon carcinoma to prevent an emergency operation. The perceived benefits remain the subject of discussion. The data-evaluating function and complications of stents in relation to radiological position are limited. METHODS: Patients receiving a preoperative stent between 2003 and 2013 were retrospectively analysed in this single-centre study. We analysed radiological deployment, eccentricity and angulation of the stent directly after placement. Endpoints were clinical success (resolution of ileus), complications needing non-elective surgery (blow-out, perforation, persistent ileus, dislocation) and other complications (bleeding, infiltrate). Associations were corrected for other potential influences. RESULTS: Eighty-two patients were included. In 22 patients (26.8%), the stent was placed proximal to the splenic flexure. Clinical success was present in 85.4%. Twenty-two patients (26.8%) had a complication of which 16 (19.5%) underwent urgent surgery for insufficient functioning of the stent; there were two blow-outs (2.4%). A more symmetrically placed stent was associated with clinical success (p = 0.042), with large overlap between groups. However, no association was found with non-elective surgery or complications. Also, angulation and deployment were unassociated with these outcomes. CONCLUSIONS: We could not establish an association between symmetry, angulation or deployment of self-expandable colonic stents with clinical success and complications.


Assuntos
Neoplasias do Colo/complicações , Obstrução Intestinal/terapia , Cuidados Pré-Operatórios/métodos , Stents Metálicos Autoexpansíveis , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças do Colo/diagnóstico por imagem , Doenças do Colo/etiologia , Doenças do Colo/terapia , Neoplasias do Colo/cirurgia , Feminino , Seguimentos , Humanos , Obstrução Intestinal/diagnóstico por imagem , Obstrução Intestinal/etiologia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Radiografia , Estudos Retrospectivos , Resultado do Tratamento
2.
Atherosclerosis ; 170(1): 59-72, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12957683

RESUMO

This randomised double-blind, placebo-controlled, clinical trial investigated the effect of 3 months of treatment with calcium dobesilate on endothelium-dependent vasodilation, markers of endothelial function, blood pressure, and markers of oxidation in obese, male smokers. Vascular effects may depend on the type of vessel and we, therefore, investigated both smaller arteries, i.e. resistance arteries and small arterioles, and large conduit arteries. Vascular function was measured by acetylcholine- and sodium-nitroprusside-mediated vasodilation, and capillary recruitment, in the skin microcirculation; by forearm blood flow (FBF) responses to several agonists and to N-G-monomethyl L-arginine (L-NMMA) in the forearm vascular bed; by flow-mediated vasodilation in the brachial artery; and by determination of soluble levels of vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1) and E-selectin. Twenty-eight individuals received dobesilate and 24 placebo. No effect of calcium dobesilate on endothelial function, blood pressure or markers of oxidation was observed compared with placebo. The difference in acetylcholine-mediated vasodilation in the microcirculation was -52.1%-point (95% confidence interval -132.8 to 28.1); in sodium-nitroprusside-mediated vasodilation in the microcirculation, 2.6%-point (-95.1 to 100.2); in capillary recruitment, 2.5%-point (-6.8 to 11.7); in acetylcholine-induced increases in FBF (n=28), 23%-point (-173 to 126); in L-NMMA-induced reduction of basal FBF, -2.8%-point (-29.3 to 23.8); in flow-mediated vasodilation of the brachial artery, 0.3%-points (-2.7 to 3.3); in 24-h systolic blood pressure, 2.1 mmHg (-1.3 to 5.5); in soluble VCAM-1, 54 ng/ml (-8 to 115); in soluble ICAM-1, 9 ng/ml (-49 to 67); in sE-selectin, -17 ng/ml (-44 to 11); in ketocholesterol 5 nM (-17 to 26); and in oxidised LDL -1.6 U/l (-6.7 to 3.5). We have shown that endothelial function, blood pressure, and markers of oxidation were not affected by 3 months of treatment with calcium dobesilate in mildly obese, smoking men. Thus, our data provide no evidence of an effect on vascular function of calcium dobesilate in humans.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Dobesilato de Cálcio/uso terapêutico , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiopatologia , Hemostáticos/uso terapêutico , Obesidade/tratamento farmacológico , Obesidade/fisiopatologia , Fumar/tratamento farmacológico , Fumar/fisiopatologia , Adolescente , Adulto , Alanina Transaminase/sangue , Biomarcadores/sangue , Monitorização Ambulatorial da Pressão Arterial , Dobesilato de Cálcio/efeitos adversos , Capilares/efeitos dos fármacos , Capilares/fisiologia , Diástole/efeitos dos fármacos , Método Duplo-Cego , Inibidores Enzimáticos/administração & dosagem , Seguimentos , Antebraço/irrigação sanguínea , Frequência Cardíaca/efeitos dos fármacos , Hemostáticos/efeitos adversos , Humanos , Cetocolesteróis/sangue , Lipoproteínas LDL/sangue , Lipoproteínas LDL/efeitos dos fármacos , Masculino , Microcirculação/efeitos dos fármacos , Pessoa de Meia-Idade , Doadores de Óxido Nítrico/uso terapêutico , Nitroprussiato/uso terapêutico , Obesidade/sangue , Oxirredução , Cooperação do Paciente , Valores de Referência , Fluxo Sanguíneo Regional/efeitos dos fármacos , Fumar/sangue , Sístole/efeitos dos fármacos , Resultado do Tratamento , Vasodilatação/efeitos dos fármacos , Vasodilatadores/uso terapêutico , ômega-N-Metilarginina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA